• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例尽管钠纠正速率正常但仍发生渗透性脱髓鞘综合征且恢复良好的病例。

A case of Osmotic demyelination syndrome despite normal rate of Sodium correction with good recovery.

作者信息

Mongolu S

机构信息

Consultant Physician & Endocrinologist Michael White Centre for Diabetes, Endocrinology and Metabolic Bone Diseases, Brocklehurst Building, Hull Royal Infirmary, Anlaby Road, HU3 2RW.

出版信息

Acute Med. 2018;17(3):160-163.

PMID:30129951
Abstract

The Osmotic demyelination syndrome (ODS) primarily occurs with rapid correction of severe hyponatraemia that has been present for more than two or three days. Some patients are, however at risk and can develop ODS at higher sodium concentration and lower rates of correction. A case of Osmotic demyelination Syndrome which developed despite an 'optimal' rate of correction of serum Sodium with good clinical outcome is described. The risk factors that contribute to development of ODS and strategies to prevent this complication are discussed, along with recommendations on how to manage this condition in hospital inpatients.

摘要

渗透性脱髓鞘综合征(ODS)主要发生于严重低钠血症快速纠正时,该低钠血症已持续两三天以上。然而,一些患者有风险,在较高钠浓度和较低纠正率情况下也可发生ODS。本文描述了一例尽管血清钠纠正速度“最佳”但仍发生渗透性脱髓鞘综合征且临床结局良好的病例。文中讨论了导致ODS发生的危险因素、预防该并发症的策略,以及关于如何在住院患者中处理这种情况的建议。

相似文献

1
A case of Osmotic demyelination syndrome despite normal rate of Sodium correction with good recovery.一例尽管钠纠正速率正常但仍发生渗透性脱髓鞘综合征且恢复良好的病例。
Acute Med. 2018;17(3):160-163.
2
The Response of Osmotic Demyelination Syndrome to Plasmapheresis in a Patient Presenting with Catatonia after Correction of Hyponatraemia in Hyperemesis Gravidarum.妊娠剧吐患者低钠血症纠正后出现紧张症,血浆置换对渗透性脱髓鞘综合征的疗效
Eur J Case Rep Intern Med. 2024 Mar 11;11(4):004373. doi: 10.12890/2024_004373. eCollection 2024.
3
Rate of Sodium Correction and Osmotic Demyelination Syndrome in Severe Hyponatremia: A Meta-Analysis.严重低钠血症时的钠纠正速率与渗透性脱髓鞘综合征:一项荟萃分析
J Crit Care Med (Targu Mures). 2024 Jul 31;10(3):209-212. doi: 10.2478/jccm-2024-0030. eCollection 2024 Jul.
4
Role of Risk Factors in Developing Osmotic Demyelination Syndrome During Correction of Hyponatremia: A Case Study.低钠血症纠正过程中危险因素在渗透性脱髓鞘综合征发生中的作用:一项病例研究
Cureus. 2020 Jan 2;12(1):e6547. doi: 10.7759/cureus.6547.
5
A case of osmotic demyelination syndrome occurred after the correction of severe hyponatraemia in hyperemesis gravidarum.一例妊娠剧吐纠正严重低钠血症后发生的渗透性脱髓鞘综合征。
BMC Endocr Disord. 2014 Apr 11;14:34. doi: 10.1186/1472-6823-14-34.
6
Central pontine myelinolysis following 'optimal' rate of correction of hyponatraemia with a good clinical outcome.低钠血症以“最佳”速度纠正后发生的中央桥脑髓鞘溶解症,临床结局良好。
Ann Clin Biochem. 2007 Sep;44(Pt 5):488-90. doi: 10.1258/000456307781646067.
7
Osmotic demyelination syndrome following rapid correction of hyponatraemia.低钠血症快速纠正后的渗透性脱髓鞘综合征
Anaesthesia. 2008 Jan;63(1):92-5. doi: 10.1111/j.1365-2044.2007.05341.x.
8
Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review.去氨加压素预防严重低钠血症时钠离子快速纠正:系统评价。
Am J Med. 2015 Dec;128(12):1362.e15-24. doi: 10.1016/j.amjmed.2015.04.040. Epub 2015 May 30.
9
Osmotic demyelination syndrome.渗透性脱髓鞘综合征。
Am J Med Sci. 2010 Jun;339(6):561-7. doi: 10.1097/MAJ.0b013e3181d3cd78.
10
Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.重度低渗性低钠血症患者:病因、评估及预后
Hosp Pract (1995). 2009 Dec;37(1):128-36. doi: 10.3810/hp.2009.12.266.

引用本文的文献

1
The Spectrum of Movement Disorders in Cases with Osmotic Demyelination Syndrome.渗透性脱髓鞘综合征病例中的运动障碍谱
Mov Disord Clin Pract. 2021 Jun 4;8(6):875-884. doi: 10.1002/mdc3.13250. eCollection 2021 Aug.
2
Osmotic demyelination syndrome following slow correction of hyponatraemia.低钠血症缓慢纠正后出现渗透性脱髓鞘综合征。
BMJ Case Rep. 2021 Aug 9;14(8):e241407. doi: 10.1136/bcr-2020-241407.